These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Frey KA; Koeppe RA; Kilbourn MR; Vander Borght TM; Albin RL; Gilman S; Kuhl DE Ann Neurol; 1996 Dec; 40(6):873-84. PubMed ID: 9007092 [TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography. Gilman S; Koeppe RA; Junck L; Kluin KJ; Lohman M; St Laurent RT Ann Neurol; 1995 Aug; 38(2):176-85. PubMed ID: 7654065 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Rinne JO; Burn DJ; Mathias CJ; Quinn NP; Marsden CD; Brooks DJ Ann Neurol; 1995 May; 37(5):568-73. PubMed ID: 7755350 [TBL] [Abstract][Full Text] [Related]
11. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. Zubieta JK; Huguelet P; Ohl LE; Koeppe RA; Kilbourn MR; Carr JM; Giordani BJ; Frey KA Am J Psychiatry; 2000 Oct; 157(10):1619-28. PubMed ID: 11007716 [TBL] [Abstract][Full Text] [Related]
12. In vivo measurement of the vesicular monoamine transporter in schizophrenia. Taylor SF; Koeppe RA; Tandon R; Zubieta JK; Frey KA Neuropsychopharmacology; 2000 Dec; 23(6):667-75. PubMed ID: 11063922 [TBL] [Abstract][Full Text] [Related]
13. Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA. Gilman S; Chervin RD; Koeppe RA; Consens FB; Little R; An H; Junck L; Heumann M Neurology; 2003 Jul; 61(1):35-9. PubMed ID: 12847153 [TBL] [Abstract][Full Text] [Related]
14. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Koeppe RA; Frey KA; Kume A; Albin R; Kilbourn MR; Kuhl DE J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605 [TBL] [Abstract][Full Text] [Related]
15. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Suzuki M; Desmond TJ; Albin RL; Frey KA Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403 [TBL] [Abstract][Full Text] [Related]
16. VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET. De La Fuente-Fernández R; Furtado S; Guttman M; Furukawa Y; Lee CS; Calne DB; Ruth TJ; Stoessl AJ Synapse; 2003 Jul; 49(1):20-8. PubMed ID: 12710012 [TBL] [Abstract][Full Text] [Related]
17. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942 [TBL] [Abstract][Full Text] [Related]
18. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study. Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128 [TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of the brain vesicular monoamine transporter. Vander Borght TM; Kilbourn MR; Koeppe RA; DaSilva JN; Carey JE; Kuhl DE; Frey KA J Nucl Med; 1995 Dec; 36(12):2252-60. PubMed ID: 8523116 [TBL] [Abstract][Full Text] [Related]
20. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Kilbourn MR; Kuszpit K; Sherman P Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]